AACR: Little Benefit Seen for Cancer Drugs Given Accelerated Approval

MONDAY, April 8, 2024-- Most cancer drugs granted accelerated approval do not demonstrate clinical benefit, according to a study published online April 7 in the Journal of the American Medical Association to coincide with the annual meeting of the...